The European Medicines Agency (EMA) says their head of vaccine strategy has been misquoted and that he does not recommend avoiding the use of the AstraZeneca vaccine for people over 60 years of age.
In an interview with the Italian newspaper La Stampa this weekend, which received a lot of attention from international media, it appeared that vaccine manager Marco Cavaleri thinks it may be worth dropping the controversial vaccine even for older adults and instead give them a vaccine from Pfizer/BioNTech or Moderna.
“In response to a specific question about giving the AstraZeneca vaccine to those over 60, Cavaleri never said that such use should cease.
“On the contrary, it is clear that the benefit-risk profile for people over 60 is favorable and that Vaxzevria should still be used,” a spokeswoman for EMA said.
She added that Cavaleri’s views are misrepresented in the interview.
“He clearly said that the benefit-risk profile is positive and that it is up to each individual country whether they want to give it to different population and age groups,” the spokeswoman added.
La Stampa later added an explanatory text to the interview.
A number of countries, including Norway, have stopped using the AstraZeneca vaccine.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at firstname.lastname@example.org